Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
2.71
Dollar change
+0.02
Percentage change
0.74
%
Index- P/E- EPS (ttm)-0.94 Insider Own2.56% Shs Outstand290.12M Perf Week0.37%
Market Cap786.23M Forward P/E- EPS next Y-0.24 Insider Trans3.50% Shs Float282.68M Perf Month14.35%
Income-74.66M PEG- EPS next Q-0.16 Inst Own63.79% Short Float3.28% Perf Quarter23.18%
Sales106.34M P/S7.39 EPS this Y40.43% Inst Trans-1.53% Short Ratio4.99 Perf Half Y-5.24%
Book/sh-1.85 P/B- EPS next Y57.14% ROA-20.93% Short Interest9.26M Perf Year36.87%
Cash/sh0.40 P/C6.84 EPS next 5Y- ROE-37.99% 52W Range1.46 - 3.16 Perf YTD22.62%
Dividend Est.- P/FCF- EPS past 5Y8.72% ROI-37.79% 52W High-14.24% Beta1.64
Dividend TTM- Quick Ratio1.26 Sales past 5Y-0.06% Gross Margin47.24% 52W Low85.62% ATR (14)0.14
Dividend Ex-Date- Current Ratio1.45 EPS Y/Y TTM61.39% Oper. Margin-60.36% RSI (14)58.62 Volatility4.22% 6.09%
Employees539 Debt/Eq0.60 Sales Y/Y TTM8.57% Profit Margin-70.21% Recom1.00 Target Price4.00
Option/ShortYes / Yes LT Debt/Eq0.21 EPS Q/Q5.49% Payout- Rel Volume1.04 Prev Close2.69
Sales Surprise13.20% EPS Surprise-4.17% Sales Q/Q4.32% EarningsFeb 28 AMC Avg Volume1.86M Price2.71
SMA203.34% SMA509.37% SMA20014.70% Trades Volume1,926,734 Change0.74%
Date Action Analyst Rating Change Price Target Change
Jul-12-23Initiated KeyBanc Capital Markets Overweight $4
Mar-18-24 08:12AM
Mar-05-24 08:27AM
Feb-29-24 06:29AM
Feb-28-24 04:41PM
04:16PM
04:01PM Loading…
04:01PM
Feb-26-24 08:00AM
Feb-22-24 04:05PM
Feb-14-24 08:30AM
Feb-07-24 08:30AM
Jan-08-24 08:30AM
Jan-05-24 08:46AM
Jan-04-24 10:23PM
09:44PM
Dec-29-23 05:04PM
04:16PM Loading…
Dec-28-23 04:16PM
Dec-26-23 03:59PM
Dec-22-23 06:57PM
Dec-21-23 08:00AM
Dec-20-23 09:00AM
Dec-17-23 03:37PM
Dec-12-23 04:32PM
Dec-11-23 10:37AM
Dec-06-23 11:18AM
Dec-04-23 08:00AM
Nov-09-23 05:54AM
Nov-08-23 12:47PM
06:52AM
Nov-07-23 04:23PM
04:00PM
08:30AM Loading…
Nov-02-23 08:30AM
Oct-25-23 08:30AM
Oct-10-23 10:22AM
Oct-05-23 02:42PM
Oct-04-23 06:49PM
08:52AM
08:00AM
Aug-09-23 09:06AM
Aug-08-23 05:36PM
04:05PM
Jul-26-23 04:05PM
Jul-25-23 04:05PM
Jul-13-23 07:33AM
Jun-14-23 07:30AM
Jun-13-23 01:30PM
May-25-23 04:05PM
May-24-23 07:11AM
06:05AM
May-18-23 07:30AM
May-15-23 07:30AM
May-10-23 02:47PM
06:16AM
May-09-23 06:11PM
04:05PM
Apr-25-23 04:30PM
Apr-20-23 05:03PM
Apr-18-23 10:42AM
Apr-17-23 08:30AM
Mar-22-23 08:30AM
Mar-15-23 08:30AM
Mar-14-23 08:30AM
Mar-01-23 04:05PM
Feb-21-23 08:30AM
Feb-17-23 06:43PM
Feb-15-23 06:01PM
Feb-14-23 04:05PM
Feb-03-23 05:30AM
Jan-31-23 08:30AM
Jan-09-23 08:30AM
Jan-03-23 08:30AM
Dec-24-22 08:01AM
Nov-28-22 08:30AM
Nov-22-22 09:20AM
Nov-11-22 05:02AM
Nov-08-22 04:05PM
Nov-07-22 04:05PM
Oct-25-22 08:30AM
Oct-13-22 08:30AM
Oct-06-22 08:30AM
Aug-25-22 04:05PM
Aug-14-22 10:38AM
Aug-08-22 04:02PM
Jul-25-22 04:30PM
Jul-04-22 11:56AM
May-05-22 04:02PM
Apr-22-22 04:02PM
Apr-11-22 08:30AM
Apr-05-22 07:30AM
Mar-29-22 08:00AM
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Casdin Partners Master Fund, LDirectorMar 05 '24Buy2.621,4033,66911,497,928Mar 06 07:20 PM
Casdin Partners Master Fund, LDirectorMar 04 '24Buy2.57250,000642,50011,496,525Mar 06 07:20 PM
Casdin Partners Master Fund, LDirectorMay 19 '23Buy2.29800,0001,835,9201,200,000May 19 09:00 PM
Casdin EliDirectorMay 19 '23Buy2.29800,0001,835,9201,200,000May 19 09:02 PM
Black Jeffrey G.SVP & Chief Financial OfficerMay 19 '23Buy2.2942,49297,21385,984May 22 06:49 PM
Casdin EliDirectorMay 18 '23Buy2.16150,000323,865400,000May 19 09:02 PM
Casdin Partners Master Fund, LDirectorMay 18 '23Buy2.16150,000323,865400,000May 19 09:00 PM
Black Jeffrey G.SVP & Chief Financial OfficerMay 18 '23Buy2.2243,49296,36543,492May 22 06:49 PM
Casdin Partners Master Fund, LDirectorMay 17 '23Buy1.89250,000471,550250,000May 19 09:00 PM
Casdin EliDirectorMay 17 '23Buy1.89250,000471,550250,000May 19 09:02 PM
Kim Hanjoon AlexChief Operating OfficerApr 04 '23Option Exercise0.0070,183070,183Apr 06 07:05 PM
Egholm MichaelPresident & CEOApr 04 '23Option Exercise0.00196,5120206,512Apr 06 07:02 PM